体质性生长延迟儿童的骨骼成熟延迟与ADHD药物使用
OBJECTIVE: To explore whether a common pathway of maturational delay underlies both attention deficit hyperactivity disorder (ADHD) and constitutional growth delay (CGD) by comparing ADHD medication use between children with CGD and children with idiopathic short stature (ISS).…
要点
- CGD患儿ADHD药物使用率(27.2%)显著高于ISS患儿(11.3%)和一般人群。
- CGD独立预测ADHD治疗(校正OR 2.17;95%CI 1.01-4.64)。
核心结论
- 在CGD患儿中,骨骼成熟延迟程度与ADHD药物使用相关,符合共同成熟延迟假说,但未确立因果关系。
研究设计与样本
- 回顾性分析2010-2025年儿科内分泌门诊随访的362名矮身材儿童(265例CGD,97例ISS),另加104例CGD的前瞻性家长问卷部分。
主要发现
- CGD独立预测ADHD治疗(校正OR 2.17;95%CI 1.01-4.64),校正了身高、BMI、性别和Tanner分期。
- 前瞻性问卷显示更大的骨龄差与更高的注意力不集中评分、行为较年龄幼稚和学业表现较低相关。
临床怎么用
- 对CGD患儿应关注ADHD症状,并考虑随骨骼成熟进展重新评估ADHD诊断。
局限性
- 研究为观察性设计,不能确立骨骼成熟延迟与ADHD之间的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore whether a common pathway of maturational delay underlies both attention deficit hyperactivity disorder (ADHD) and constitutional growth delay (CGD) by comparing ADHD medication use between children with CGD and children with idiopathic short stature (ISS). STUDY DESIGN: Retrospective review of 362 short-statured children (265 CGD, 97 ISS) followed in a pediatric endocrinology clinic (2010-2025), plus a prospective parent-questionnaire component (n = 104 CGD). ADHD medication use (Rx) was the primary outcome. Logistic regression adjusted for height, body mass index, sex, and Tanner stage. RESULTS: ADHD Rx was significantly higher in CGD than in ISS (27.2% vs 11.3%, P = .002) and the general population (P < .001); ISS rates did not differ from population norms (P = .76). ADHD Rx showed a dose-response relationship with bone age gap (BAG) across the retrospective cohort as a whole, reaching 35.1% for BAG ≥3 years (P < .001 for trend). CGD independently predicted ADHD treatment (adjusted OR 2.17; 95% CI 1.01-4.64). Greater BAG was associated with higher inattention scores, younger-than-age behavior, and lower academic performance on prospective questionnaires. CONCLUSIONS: The degree of skeletal maturation delay correlates with ADHD medication use in CGD, consistent with a shared maturational delay hypothesis but not establishing causality. These findings may warrant careful re-evaluation of ADHD diagnoses as skeletal maturation progresses in affected children.
引用
- Cahn R, Michaely SA, Gillis D, et al. Skeletal Maturation Delay and ADHD Medication Use in Children with Constitutional Growth Delay: A Retrospective-Prospective Study. J Pediatr. 2026. PMID: 42716242. doi:10.1016/j.jpeds.2026.115320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。